Adding ru58841 powder into minoxidil bottle ? Is it a thing ? Product 9/3/2024
Adding RU58841 powder to Minoxidil solution for hair loss treatment. Users recommend Actifolic as a source for RU58841 powder.
View this post in the Community →
Similar Community Posts Join
5 / 5 resultscommunity Actifolic RU58841 and others Scam?
Actifolic's RU58841 and Pyri products are perceived as ineffective, with users reporting no side effects or improvements, suggesting possible quality issues. Users recommend alternative sources and emphasize the importance of timing when using RU58841 with Minoxidil.
community Creatine's effect on Hair Loss and DHT
A 21-year-old male managed to control his hair loss using Nizoral, RU58841, and finasteride, but experienced increased scalp itchiness after starting creatine, which subsided upon stopping creatine. Users shared mixed experiences on whether creatine affects hair loss, with some reporting negative effects and others seeing no change or defending its benefits.
community Lab results from actifolic RU58841
The post discusses the user's experience with hair loss treatment RU58841, which was tested for quality and found to be 96+% pure. The conversation includes various responses, with some users questioning the safety of the product and others expressing satisfaction with the test results.
community Does low HGH leading to hairloss?
The user experiencing diffuse hair loss is using various treatments including RU58841, finasteride, minoxidil with tretinoin, anti-hair loss shampoo, and microneedling, and is considering adding peptides TB500, BPC157, and GHK-Cu. They have low growth hormone levels and are questioning its impact on hair loss, while another user suggests androgenic alopecia and androgens are likely the main cause of hair loss.
community Why does hairloss look great one day and regression the next?
Hair appearance fluctuates due to factors like styling, product buildup, and humidity, causing frustration for those with diffuse thinning. Treatments mentioned include minoxidil, finasteride, ketoconazole shampoo, and RU58841, with mixed results.
Related Research
6 / 6 results
research The new paradigm for androgenetic alopecia and plant-based folk remedies: 5α-reductase inhibition, reversal of secondary microinflammation and improving insulin resistance
This review discusses the role of inheritance, androgens, and microinflammation in androgenetic alopecia and suggests some plant-based folk remedies may help address these factors but reports no new clinical results.
research EXPERIENCE IN TREATMENT OF DIFFUSE HAIR LOSS
In this article, the authors concluded that despite diverse causes of diffuse hair loss, modern therapies can effectively manage the condition without side effects, as demonstrated in two clinical cases of telogen effluvium.
research FEMALE PATTERN HAIR LOSS. MODERN CONCEPTS OF ETIOPATHOGENESIS, CLINICAL FEATURES, DIAGNOSTICS, COMPLEX TREATMENT METHODS
This review explores recent insights into the causes, clinical features, diagnosis, and comprehensive treatments of female-pattern hair loss, emphasizing the importance of trichoscopy and highlighting approaches like nutritional correction and various therapies including low-intensity lasers and PRP.
research Hair loss: The role of nutritional support in a comprehensive approach to hair loss treatment
In this study, women with telogen effluvium showed significant improvement in hair loss and hair growth density when treated with a combination of oral Pantovigar, a Microxidil-containing topical lotion, and mesotherapy with a placental preparation compared to those not receiving Pantovigar.
research The effect of topical RU58841 (androgen receptor blocker) combined with minoxidil on hair growth in macaque androgenetic alopecia
Combining RU58841 and minoxidil significantly increases hair growth.
research Haarverlies volgens het vrouwelijk patroon (female pattern hair loss).
This article reviews female pattern hair loss in women, highlighting its characteristics, treatment options, and the need to differentiate it from other hair loss conditions, and reports no new clinical results.